World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Professor John Axford - Professor of Rheumatology (MD., DSc, F.R.C.P.)

Professor John Axford studied medicine at University College, London in 1989. He was chosen as a Fulbright Scholar and performed research in various areas of immunology both at the Middlesex Hospital Medical School, and Tufts University, USA. In 1990, Professor Axford completed his research thesis in arthritic diseases and in 1991 was awarded his M.D. with a Specialist Accreditation in Rheumatology and Immunology.

He has lectured extensively throughout the United States, the United Kingdom, Europe, Australia, and Asia and has authored or co-authored over 80 published peer-reviewed scientific papers, over 128 published abstracts and letters, and 18 medical textbooks. Professor Axford is a past section President of the Royal Society of Medicine and currently serves on the Editorial Boards of three medical journals and on numerous medical and health related committees. He is also Editor of the Undergraduate textbook 'Medicine'.

At present, Professor Axford is the Professor of Clinical Rheumatology and the Director of Sir Joseph Hotung Centre for Musculoskeletal Disorders for St George's University of London, where he directs the provision of clinical and basic scientific research, clinical care and both undergraduate and postgraduate education. He joined St George's University of London in 1990 and was appointed Chair of Clinical Rheumatology in 2005.

Currently, Professor Axford is serving as the Principal Investigator for 2 three-year clinical trials funded by St. George's University of London and NHS Hospital.

Back to experts

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Making gains in drug development

September 2, 2021
Keith Berelowitz outlines the innovations in the design and delivery of clinical trials
Read more

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

September 2, 2021
This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.
Read more

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more